Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Wally Mastroly who wrote (699)	7/14/1999 9:02:00 AM
From: out_of_the_loop	Read Replies (1) \| Respond to of 5582

VPHM pleconaril vs. Zicam I am not concerned about pleconaril because it is a prescription drug that will be: 1. Expensive 2. Not available easily to the general public. 3. Two years too late by the time it might be considered any competition. 4. available after you have a cold for several days. What percent of people can get into see a doctor for a COLD in less than a day? It will take more than 2 days to get to a doctor to obtain. See #2. You will be able to buy Zicam in any Walmart, KMart,Buy-Rite,Albertosn's, Target, and many others just 8-12 weeks from NOW. 5. Being tested on especially aggressive upper respiratory tract infections. The only place it might be competition is in the hospitalized immunosuppressed. The HMOs might pay for Zicam as a first line, but I doubt the other as a first line without "approval". 6. Who knows the side effects? Antivirals often have unpleasant side effects that we probably do not need to get into. While I understand the curiosity and certainly would monitor the situation, I think in 1999-2000 Zicam is the winner. The effectiveness of pleconaril will not take away any of the cost and OTC advantages of Zicam since people are generally pretty practical these days when it comes to cheaper, faster alternatives.